MedPath

Resiliency Training for Adolescents With Craniofacial Conditions and Their Caregivers

Not Applicable
Withdrawn
Conditions
Craniofacial Abnormalities
Interventions
Behavioral: SMART-3RP
Registration Number
NCT02562339
Lead Sponsor
Massachusetts General Hospital
Brief Summary

This is a prospective study that will examine psychosocial improvements among CF adolescents and caregivers going through the Stress Management and Resiliency Training - Relaxation Response Resiliency Program (SMART-3RP).

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria
  1. Unable to benefit from the program due to cognitive, psychiatric or other reasons based on the opinion of the group leader
  2. Unable or unwilling to sign the informed consent documents

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SMART-3RP for Adolescent PatientsSMART-3RPParticipants will receive an 8-week behavioral intervention which teaches stress management and psychological resiliency-enhancing skills.
SMART-3RP for Parents or CaregiversSMART-3RPParticipants will receive an 8-week behavioral intervention which teaches stress management and psychological resiliency-enhancing skills.
Primary Outcome Measures
NameTimeMethod
The 14-Item Resiliency Scale (RS-14)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The RS-14 measures stress coping ability in the face of adversity.

Quality of Life (WHOQOL-BREF)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The WHOQOL-BREF comprises of 26 items which measure the following broad domains: physical health, psychological health, social relationships, and environment. The WHOQOL-BREF is a shorter version of the original instrument that may be more convenient for use in large research studies or clinical trials.

Secondary Outcome Measures
NameTimeMethod
Satisfaction with Life (SWL)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The Satisfaction with Life (SWL) scale is a reliable and valid 5-item self-report measure of global life satisfaction. Responses are made on a 7-point scale with higher scores reflecting higher life satisfaction.

Patient Health Questionnaire (PHQ) - caregivers onlyChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The PHQ measures symptoms of depression and functional impairment.

Child and Adolescent Mindfulness Measure (CAMM) - patients onlyChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Assesses mindfulness in children and adolescents

The Gratitude Questionnaire (GQ-6)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The GQ-6 revised is a 6-item measure that assesses individual differences in the proneness to experience gratitude in daily life. Scores range from 6-42, with a higher score indicating a greater sense of gratitude.

Measure of Current Status (MOCS-A)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The MOCS-A is a 13-item measure assessing participants' current self-perceived status on several skills such as: the ability to relax at will, recognize stress-inducing situations, restructure maladaptive thoughts, be assertive about needs, and choose appropriate coping responses as needed. Responses are made on a 7-point scale with higher scores reflecting higher life satisfaction.

Patient Health Questionnaire for Adolescents (PHQ-A) - patients onlyChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Symptoms of depression and functional impairment

Generalized Anxiety Disorder 7-item (GAD-7)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

A brief measure for assessing generalized anxiety disorder

Cognitive and Affective Mindfulness Scale (CAMS) - caregivers onlyChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The CAMS measures the degree to which individuals experience their thoughts and feelings.

Interpersonal Reactivity Index (IRI)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The IRI assesses the cognitive and affective dimensions of empathy.

Perceived Stress Scale (PSS-10)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The PSS is a widely used psychological instrument for the measurement of the perception of stress. This 10-itam scale is designed to measure the degree to which situations in one's life are appraised, or considered stressful. The scores range from 0-40, with a higher score indicating higher perceived stress. Items were designed to detect how unpredictable, uncontrollable and overloaded respondents find their lives.

Distress Analogue ScalesChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The Distress Analogue Scales measure participants' levels of stress, coping, distress, and discomfort.

Medical Outcomes Study (MOS) Social Support SurveyChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The MOS Social Support Survey measures various dimensions of social support.

Life Orientation Test (LOT) Optimism ScaleChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

The LOT Optimism Scale measures individual differences in generalized optimism versus pessimism.

Rosenberg Self Esteem Scale (RES)Change between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Assesses levels of self esteem

The Body Image Quality of Life Inventory (BIQLI) - patients onlyChange between Baseline (week 0), Post-intervention (week 8) and Follow Up (week 32)

Measures patients' perception of their own body image and how it relates to quality of life.

Trial Locations

Locations (1)

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath